US Stock MarketDetailed Quotes
HGENQ Humanigen
- 0.000
- 0.0000.00%
15min DelayClose May 22 16:00 ET
23.82KMarket Cap0.00P/E (TTM)
0.000High0.000Low7.35KVolume0.000Open0.000Pre Close1.47Turnover0.01%Turnover Ratio0.00P/E (Static)119.08MShares0.20752wk High0.00P/B21.34KFloat Cap0.00052wk Low--Dividend TTM106.68MShs Float29.200Historical High--Div YieldTTM0.00%Amplitude0.000Historical Low0.000Avg Price1Lot Size
About Humanigen Company
Humanigen, Inc. is a clinical-stage biopharmaceutical company. engages in the development of cell and gene therapies for the treatment of cancers through novel human granulocyte-macrophage colony-stimulating factor neutralization and gene-knockout platforms. The company was founded by Jeng-Horng Her & Robert F. Balint on March 15, 2000 and is headquartered in Essex County, NJ.
Company Profile
SymbolHGENQ
Company NameHumanigen
Founded2000
CEODr. Cameron Durrant
MarketPink Market
Employees6
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address830 Morris Turnpike,4th floor,Short Hills
CityEssex County
ProvinceNew Jersey
CountryUnited States of America
Zip Code07078
Phone1-973-200-3100
Websitehttp://www.humanigen.com
Company Executives
- Name
- Position
- Salary
- Dr. Cameron Durrant
- Chairman of the Board, Chief Executive Officer, Acting Chief Financial Officer and Principal Accounting Officer
- --
- Edward P. Jordan
- Chief Commercial Officer
- --
- Dr. Dale Chappell, M.D.
- Director and Chief Scientific Officer
- --
- Ronald Barliant
- Independent Director
- --
- Rainer J. Boehm, M.B.A.
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg